FDA approves oral ganciclovir as first drug to prevent CMV disease. Food and Drug Administration.
Baker
R
R
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy*; D000284:Administration, Oral; D000998:Antiviral Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D003586:Cytomegalovirus Infections / Q000150:complications / Q000188:drug therapy*; D017726:Cytomegalovirus Retinitis / Q000150:complications / Q000188:drug therapy*; D017277:Drug Approval; D016527:Drug Costs; D015774:Ganciclovir / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D014481:United States; D014486:United States Food and Drug Administration
D000998:Antiviral Agents; D015774:Ganciclovir